Host responses

Host responses represent the integrated biological and physiological reactions of an organism to pathogens, injury, or other external stressors. These responses are mediated by a vast array of molecular pathways, including innate and adaptive immunity, the inflammatory cascade, and cellular processes such as autophagy and apoptosis [1][2]. In pharmacological research, the term often refers to the focus of 'host-directed therapies' (HDTs), which aim to optimize these reactions to improve clinical outcomes in infectious or inflammatory diseases [2][5]. For example, HDTs may use corticosteroids to suppress excessive inflammation in sepsis or biologics to neutralize specific cytokines like TNF-alpha [4][8].\n\nBecause host responses involve the coordinated action of thousands of genes and proteins across multiple organ systems, the term does not denote a single discrete therapeutic target but rather a complex phenotypic category [4][10]. Effective drug development requires identifying specific 'hubs' or individual molecules within these responses, such as pattern recognition receptors or signal-transmitting kinases, for precise intervention [1][6]. Consequently, while 'Host responses' is a foundational concept in pathology and drug discovery, it is considered too broad to be classified as an individual molecular target in drug development databases.

Other names

Host immune responseHost inflammatory responseHost-pathogen interaction responseHost-directed responseHost transcriptional response programs

Modulation of specific components of host biological pathways—such as immune signaling, inflammatory cascades, or metabolic processes—to either enhance pathogen elimination or reduce immune-mediated tissue damage.